88 related articles for article (PubMed ID: 24651062)
1. Duloxetine may enhance control of pain related to bladder trauma.
Hsu CC; Ku SC; Chang HA; Kao YC; Tzeng NS
Aust N Z J Psychiatry; 2014 Sep; 48(9):881. PubMed ID: 24651062
[No Abstract] [Full Text] [Related]
2. Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.
Lai CH
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):240-1. PubMed ID: 19833160
[No Abstract] [Full Text] [Related]
3. Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
Tomita T; Yasui-Furukori N; Kaneko S
Clin Neuropharmacol; 2013; 36(5):175-6. PubMed ID: 24045610
[TBL] [Abstract][Full Text] [Related]
4. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C
Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC
Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888
[TBL] [Abstract][Full Text] [Related]
6. Response to duloxetine in a depressed, treatment-resistant adolescent female.
Delgado SV; Saldaña SN; Barzman DH; Coffey B
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):889-94. PubMed ID: 18315460
[No Abstract] [Full Text] [Related]
7. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
Demyttenaere K; Desaiah D; Petit C; Croenlein J; Brecht S
Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
[TBL] [Abstract][Full Text] [Related]
8. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
Wang J; Liu X; Mullins CD
Curr Med Res Opin; 2011 Jul; 27(7):1303-13. PubMed ID: 21561393
[TBL] [Abstract][Full Text] [Related]
9. Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E24-5. PubMed ID: 23037667
[No Abstract] [Full Text] [Related]
10. Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E40-1. PubMed ID: 21677224
[No Abstract] [Full Text] [Related]
11. A word of caution about the implied role for duloxetine in pain management.
Leo RJ
J Clin Psychiatry; 2003 Oct; 64(10):1270. PubMed ID: 14658982
[No Abstract] [Full Text] [Related]
12. Safety of electroconvulsive therapy-duloxetine combination.
Eraslan D; Genc Y; Odabasioglu G; Ergun BM; Ozturk O
J ECT; 2011 Sep; 27(3):e51-2. PubMed ID: 21865952
[No Abstract] [Full Text] [Related]
13. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine fights major depressive disorder.
Wimett L; Laustsen G
Nurse Pract; 2005 Mar; 30(3):6-7. PubMed ID: 15753808
[No Abstract] [Full Text] [Related]
16. Effects of baseline depression severity on remission rates with duloxetine and placebo in anxious and nonanxious patients with major depression.
Nelson JC
J Clin Psychopharmacol; 2011 Oct; 31(5):682-4. PubMed ID: 21881463
[No Abstract] [Full Text] [Related]
17. Duloxetine use in painful conditions.
Marcus DA
Expert Opin Pharmacother; 2011 Jun; 12(8):1333-1340. PubMed ID: 21548724
[No Abstract] [Full Text] [Related]
18. Measurement of pain and medication effect in a study of duloxetine.
Griffith JM; Hasley JP; Severn DG
J Clin Psychiatry; 2008 Jun; 69(6):1022. PubMed ID: 18684005
[No Abstract] [Full Text] [Related]
19. Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom.
Shi N; Cao Z; Durden E; Schacht A; Torres A; Happich M
J Med Econ; 2012; 15(4):672-80. PubMed ID: 22390770
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder.
Houston JP; Zou W; Aris V; Fijal B; Chen P; Heinloth AN; Martinez J
Psychiatry Res; 2012 Nov; 200(1):63-5. PubMed ID: 22727709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]